Michael Charles Iannuzzi
Physician at Chaucer Dr, Ann Arbor, MI
License number
Colorado 25427
Issued Date
Jul 14, 1983
Renew Date
May 31, 1987
Expiration Date
May 31, 1987
Type
Physician
Address
Address
2073 Chaucer Dr, Ann Arbor, MI 48013
Professional information
Cystic Fibrosis Gene
US Patent:
6730777, May 4, 2004
Filed:
Jun 6, 1995
Appl. No.:
08/469630
Inventors:
Lap-Chee Tsui - Toronto, CA
John R. Riordan - Toronto, CA
Francis S. Collins - Ann Arbor MI
Johanna M. Rommens - Willowdale, CA
Michael C. Iannuzzi - Ann Arbor MI
Bat-Sheva Kerem - Toronto, CA
Mitchell L. Drumm - Ann Arbor MI
Manuel Buchwald - Toronto, CA
John R. Riordan - Toronto, CA
Francis S. Collins - Ann Arbor MI
Johanna M. Rommens - Willowdale, CA
Michael C. Iannuzzi - Ann Arbor MI
Bat-Sheva Kerem - Toronto, CA
Mitchell L. Drumm - Ann Arbor MI
Manuel Buchwald - Toronto, CA
Assignee:
HSC Research Development Corporation - Toronto
University of Michigan - Ann Arbor MI
University of Michigan - Ann Arbor MI
International Classification:
C07K 1400
US Classification:
530350
Abstract:
The cystic fibrosis gene and its gene product are described for both the normal and mutant forms. The genetic and protein information is used in developing DNA diagnosis, protein diagnosis, carrier and patient screening, drug and gene therapy, cloning of the gene and manufacture of the protein, and development of cystic fibrosis affected animals.
Cystic Fibrosis Gene
US Patent:
6902907, Jun 7, 2005
Filed:
Jun 2, 1994
Appl. No.:
08/252778
Inventors:
Lap-Chee Tsui - Toronto, CA
John R. Riordan - Toronto, CA
Francis S. Collins - Ann Arbor MI, US
Johanna M. Rommens - Willowdale, CA
Michael C. Iannuzzi - Ann Arbor MI, US
Bat-Sheva Kerem - Toronto, CA
Mitchell L. Drumm - Ann Arbor MI, US
Manuel Buchwald - Toronto, CA
John R. Riordan - Toronto, CA
Francis S. Collins - Ann Arbor MI, US
Johanna M. Rommens - Willowdale, CA
Michael C. Iannuzzi - Ann Arbor MI, US
Bat-Sheva Kerem - Toronto, CA
Mitchell L. Drumm - Ann Arbor MI, US
Manuel Buchwald - Toronto, CA
Assignee:
HSC Research Development Corporation - Toronto
The Board of Regents Acting for and on Behalf of The University of Michigan - Ann Arbor MI
The Board of Regents Acting for and on Behalf of The University of Michigan - Ann Arbor MI
International Classification:
C12P021/06, C07K014/00
US Classification:
435 691, 4352523, 4353201, 435325, 536 231, 530350
Abstract:
The cystic fibrosis gene and its gene product are described for both the normal and mutant forms. The genetic and protein information is used in developing DNA diagnosis, protein diagnosis, carrier and patient screening, drug and gene therapy, cloning of the gene and manufacture of the protein, and development of cystic fibrosis affected animals.
Cystic Fibrosis Gene
US Patent:
6984487, Jan 10, 2006
Filed:
Sep 20, 1993
Appl. No.:
08/123864
Inventors:
Lap-Chee Tsui - Toronto, CA
John R. Riordan - Toronto, CA
Francis S. Collins - Ann Arbor MI, US
Johanna M. Rommens - Willowdale, CA
Michael C. Iannuzzi - Ann Arbor MI, US
Bat-Sheva Kerem - Toronto, CA
Mitchell L. Drumm - Ann Arbor MI, US
Manuel Buchwald - Toronto, CA
John R. Riordan - Toronto, CA
Francis S. Collins - Ann Arbor MI, US
Johanna M. Rommens - Willowdale, CA
Michael C. Iannuzzi - Ann Arbor MI, US
Bat-Sheva Kerem - Toronto, CA
Mitchell L. Drumm - Ann Arbor MI, US
Manuel Buchwald - Toronto, CA
Assignee:
HSC Research Development Corporation - Toronto
The Board of Regents Acting For and on Behalf of The University of Michigan - Ann Arbor MI
The Board of Regents Acting For and on Behalf of The University of Michigan - Ann Arbor MI
International Classification:
C12Q 1/68, C07K 14/00, C07H 21/04
US Classification:
435 6, 536 231, 530350
Abstract:
The cystic fibrosis gene and its gene product are described for both the normal and mutant forms. The genetic and protein information is used in developing DNA diagnosis, protein diagnosis, carrier and patient screening, drug and gene therapy, cloning of the gene and manufacture of the protein, and development of cystic fibrosis affected animals.
Cystic Fibrosis Gene
US Patent:
6201107, Mar 13, 2001
Filed:
Jun 6, 1995
Appl. No.:
8/469617
Inventors:
Tsui Lap-Chee - Toronto, CA
John R. Riordan - Toronto, CA
Francis S. Collins - Ann Arbor MI
Johanna M. Rommens - Willowdale, CA
Michael C. Iannuzzi - Ann Arbor MI
Bat-Sheva Kerem - Toronto, CA
Mitchell L. Drumm - Ann Arbor MI
Manuel Buchwald - Toronto, CA
John R. Riordan - Toronto, CA
Francis S. Collins - Ann Arbor MI
Johanna M. Rommens - Willowdale, CA
Michael C. Iannuzzi - Ann Arbor MI
Bat-Sheva Kerem - Toronto, CA
Mitchell L. Drumm - Ann Arbor MI
Manuel Buchwald - Toronto, CA
Assignee:
HSC Research Development Corporation - Toronto
The Board of Regents, Acting for and on Behalf of the University of
Michigan - Ann Arbor MI
The Board of Regents, Acting for and on Behalf of the University of
Michigan - Ann Arbor MI
International Classification:
C07K 1600, A61K 39395
US Classification:
5303871
Abstract:
The cystic fibrosis gene and its gene product are described for both the normal and mutant forms. The genetic and protein information is used in developing DNA diagnosis, protein diagnosis, carrier and patient screening, drug and gene therapy, cloning of the gene and manufacture of the protein, and development of cystic fibrosis affected animals.
Methods Of Detecting Cystic Fibrosis Gene By Nucleic Acid Hybridization
US Patent:
5776677, Jul 7, 1998
Filed:
Jun 6, 1995
Appl. No.:
8/466886
Inventors:
Lap-Chee Tsui - Toronto, CA
John R. Riordan - Toronto, CA
Francis S. Collins - Ann Arbor MI
Johanna M. Rommens - Willowdale, CA
Michael C. Iannuzzi - Ann Arbor MI
Bat-Sheva Kerem - Toronto, CA
Mitchell L. Drumm - Ann Arbor MI
Manuel Buchwald - Toronto, CA
John R. Riordan - Toronto, CA
Francis S. Collins - Ann Arbor MI
Johanna M. Rommens - Willowdale, CA
Michael C. Iannuzzi - Ann Arbor MI
Bat-Sheva Kerem - Toronto, CA
Mitchell L. Drumm - Ann Arbor MI
Manuel Buchwald - Toronto, CA
Assignee:
HSC Research Development Corporation - Toronto
The Board of Regents, Acting for and on Behalf of The University of
Michigan - Ann Arbor MI
The Board of Regents, Acting for and on Behalf of The University of
Michigan - Ann Arbor MI
International Classification:
C12Q 168, G12P 1934, C07H 2104, C07H 2102
US Classification:
435 6
Abstract:
The cystic fibrosis gene and its gene product are described for both the normal and mutant forms. The genetic and protein information is used in developing DNA diagnosis, protein diagnosis, carrier and patient screening, drug and gene therapy, cloning of the gene and manufacture of the protein, and development of cystic fibrosis affected animals.